ITUS Corp.

ITUS Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.6
Market Cap
$74.57 M
Shares Outstanding
18.7 M
Public Float
16.26 M

Profile

Address
3150 Almaden Expressway
San Jose California 95118
United States
Employees -
Website http://www.ituscorp.com
Updated 09/14/2018
ITUS Corp. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Financials

View All

Amit Kumar
Executive Chairman, President & CEO
Richard H. Williams
Independent Director